Obesity, serum prostate specific antigen and prostate size: Implications for prostate cancer detection

Journal of Urology

Volumn 175, Issue 2, 2006, Pages 500-504

  Freedland, Stephen J ^a,j   Platz, Elizabeth A ^a,b,c   Presti Jr , Joseph C ^d   Aronson, William J ^e   Amling, Christopher L ^f   Kane, Christopher J ^g,h   Terris, Martha K ⁱ  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^g Veterans Administration   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ VETERANS AFFAIRS MEDICAL CENTER   (United States)

^j DUKE UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

Obesity; Prostate; Prostate specific antigen; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER GRADING; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATECTOMY;

HUMANS; MALE; MIDDLE AGED; OBESITY; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 30344476141     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)00162-X     Document Type: Article

References (21)

1. K.M. Flegal, M.D. Carroll, C.L. Ogden, C.L. Johnson Prevalence and trends in obesity among US adults, 1999-2000 JAMA 288 2002 1723
2. G.A. Bray The underlying basis for obesity relationship to cancer J Nutr 132 suppl 2002 3451S
3. S.O. Andersson, A. Wolk, R. Bergstrom, H.O. Adami, G. Engholm, A. Englund Body size and prostate cancer a 20-year follow-up study among 135006 Swedish construction workers J Natl Cancer Inst 89 1997 385
4. A. Engeland, S. Tretli, T. Bjorge Height, body mass index, and prostate cancer a follow-up of 950000 Norwegian men Br J Cancer 89 2003 1237
5. A.G. Schuurman, R.A. Goldbohm, E. Dorant, P.A. van den Brandt Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study Am J Epidemiol 151 2000 541
6. A.S. Whittemore, L.N. Kolonel, A.H. Wu, E.M. John, R.P. Gallagher, G.R. Howe Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada J Natl Cancer Inst 87 1995 652
7. E. Giovannucci, E.B. Rimm, Y. Liu, M. Leitzmann, K. Wu, M.J. Stampfer Body mass index and risk of prostate cancer in U.S. health professionals J Natl Cancer Inst 95 2003 1240
8. S.E. Dahle, A.P. Chokkalingam, Y.-T. Gao, J. Deng, F.Z. Stanczyk, A.W. Hsing Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia J Urol 168 2002 599
9. J. Hammarsten, B. Hogstedt Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia Eur Urol 39 2001 151
10. S.J. Freedland, C.L. Amling, F. Dorey, C.J. Kane, J.C. Presti Jr., M.K. Terris Race as an outcome predictor after radical prostatectomy results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database Urology 60 2002 670
11. J.S. Lewis Jr., R.T. Vollmer, P.A. Humphrey Carcinoma extent in prostate needle biopsy tissue in the prediction of whole gland tumor volume in a screening population Am J Clin Pathol 118 2002 442
12. R.O. Roberts, D.J. Jacobson, C.J. Girman, T. Rhodes, G.G. Klee, M.M. Lieber Insulin-like growth factor I, insulin-like growth factor binding protein 3, and urologic measures of benign prostatic hyperplasia Am J Epidemiol 157 2003 784
13. A.W. Partin, J.E. Oesterling, J.I. Epstein, R. Horton, P.C. Walsh Influence of age and endocrine factors on the volume of benign prostatic hyperplasia J Urol 145 1991 405
14. X. Cai, R. Haleem, S. Oram, J. Cyriac, F. Jiang, J.T. Grayhack High fat diet increases the weight of rat ventral prostate Prostate 49 2001 1
15. J. Baillargeon, B.H. Pollock, A.R. Kristal, P. Bradshaw, J. Hernandez, J. Basler The association of body mass index and prostate-specific antigen in a population-based study Cancer 103 2005 1092
16. M.A. Gray, B. Delahunt, J.R. Fowles, P. Weinstein, R.R. Cookes, J.N. Nacey Demographic and clinical factors as determinants of serum levels of prostate specific antigen and its derivatives Anticancer Res 24 2004 2069
17. J.H. Ku, M.E. Kim, N.K. Lee, Y.H. Park, J.O. Ahn Influence of age, anthropometry, and hepatic and renal function on serum prostate-specific antigen levels in healthy middle-age men Urology 61 2003 132
18. R. Kranse, P. Beemsterboer, J. Rietbergen, D. Habbema, J. Hugosson, F.H. Schroder Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region) Prostate 39 1999 316
19. P. Finne, R. Finne, A. Auvinen, H. Juusela, J. Aro, L. Maattanen Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network Urology 56 2000 418
20. S.J. Freedland, M.K. Terris, E.A. Platz, J.C. Presti Jr. Body mass index as a predictor of prostate cancer development versus detection on biopsy Urology 66 2005 108
21. L. Salomon, O. Levrel, A.G. Anastasiadis, J. Irani, A. De La Taille, F. Saint Prognostic significance of tumor volume after radical prostatectomy a multivariate analysis of pathological prognostic factors Eur Urol 43 2003 7739